Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Arteriocyte Inc.
DescriptionHuman umbilical cord blood-derived stem cell therapy
Molecular Target Not applicable
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Stem cell
Latest Stage of DevelopmentPreclinical
Standard IndicationIschemia / reperfusion injury
Indication DetailsTreat critical limb ischemia (CLI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today